Prompted by the pandemic, the Endocrinology & Metabolism Institute transitioned outpatient visits to telemedicine in a matter of days. In this article, institute leadership discusses the transition and what their practice might look like after COVID-19.
The annual conference, which takes place in Cleveland and Baton Rouge, provide clinicians the latest on the science and treatment of obesity and its comorbidities.
Hospitals seeking to undertake a self-management approach to diabetes care need to draft clear institutional policies. A closer look at results of a Cleveland Clinic study.
Cleveland Clinic’s first total face transplant recipient also faced substantial endocrinological challenges, including pituitary gland dysfunction and diabetes insipidus. Chairman Laurence Kennedy, MD, FRCP, explains how his endocrinology team ensured a good outcome.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
More information is needed about disease pathogenesis, response to treatment and how we prevent complications. Cole Eye Institute’s Rishi Singh, MD, reviews research underway.
Following two previous bariatric surgeries elsewhere, a 45-year-old woman undergoes a revision to a distal gastric bypass with outstanding results.
Immunobiology of beta cell failure, genetic diabetes and islet cell therapy are among focal points of our “3rd Annual Beta Cell Symposium” CME course Nov. 9-10.
For the first time, research suggests that Akt3 protects against diet-related obesity in a preclinical model by suppressing a mechanism of adipogenesis. Eugene Podrez, MD, PhD, explains.
A number of popular diets are reviewed as well as studies evaluating the effect of various diets on weight loss, diabetes and cardiovascular risk factors.
With many first-line oral treatments for type 2 diabetes associated with weight gain, healthcare providers are faced with a therapeutic dilemma. Should they focus their efforts on improving patients’ glycemic control or helping these patients lose weight? A closer look at the dilemma, the drugs and the direction for better diabetes control.